Futura Medical (GB:FUM) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Futura Medical PLC, a company trading on the AIM market under the ticker FUM and specializing in innovative sexual health products, announced its total issued share capital stands at 302,403,003 Ordinary Shares, with the same number of voting rights as no shares are held in treasury. The company highlighted its lead product Eroxon, a unique topical gel for treating Erectile Dysfunction that works in ten minutes and is available over the counter. They also boast of strategic distribution partnerships across major consumer markets, including the US and Europe.
For further insights into GB:FUM stock, check out TipRanks’ Stock Analysis page.